title: Neuropsychiatric adverse events and oseltamivir for prophylaxis.
authors.forename: Mark
authors.initials: M
authors.lastname: Jones
authors.forename: Rokuro
authors.initials: R
authors.lastname: Hama
authors.forename: Tom
authors.initials: T
authors.lastname: Jefferson
authors.forename: Peter
authors.initials: P
authors.lastname: Doshi
mesh_terms: D000998:Antiviral Agents / Q000009:adverse effects*; D006801:Humans; D007251:Influenza, Human / Q000188:drug therapy*; D001523:Mental Disorders / Q000139:chemically induced*; D053139:Oseltamivir / Q000009:adverse effects*; D016032:Randomized Controlled Trials as Topic
chemical_list: D000998:Antiviral Agents; D053139:Oseltamivir